Product Data Sheet

Ralaniten

Catalog No. A84931

main product photo
Ralaniten is a potent and orally active antagonist of the androgen receptor N-terminal domain (AR-NTD). It effectively inhibits AR transcriptional activity, displaying an IC50 of 7.4 μM. Ralaniten is primarily applied in research concerning castration-resistant prostate cancer (CRPC), offering insights into potential therapeutic strategies targeting this condition.
Chemical Information
Catalog NumA84931
M. Wt394.89
FormulaC21H27ClO5
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.1203490-23-6
SynonymsEPI-002
SMILESCC(C1=CC=C(OC[C@H](O)CCl)C=C1)(C2=CC=C(OC[C@H](O)CO)C=C2)C
Biological Activity
DescriptionRalaniten is a potent and orally active antagonist of the androgen receptor N-terminal domain (AR-NTD). It effectively inhibits AR transcriptional activity, displaying an IC50 of 7.4 μM. Ralaniten is primarily applied in research concerning castration-resistant prostate cancer (CRPC), offering insights into potential therapeutic strategies targeting this condition.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.